Recapture of Day 1 Suchart Chongprasert, Ph.D. Food and Drug Administration “Practical Aspects in Performing Clinical and Bioanalytical Parts in BA/BE.

Slides:



Advertisements
Similar presentations
1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team.
Advertisements

Essential Documentation GCP Training Seminar 12th October 2011
Tips to a Successful Monitoring Visit
HOT TOPICS ARCHIVING OR HOW NOT TO DUMP YOUR RUBBISH!
GCP for Investigators Tina Lidén Mascher, Kvalitetsregister, forskning och industrisamarbeten.
Audit Ebru Mutlu-Omega CRO. General Purpose to help quality (to maintain quality at present) to assure quality (make sure that quality in future is maintained)
Verifying Source Documents. 2 Source Documentation First place the data are captured Original documents, data, and records Certified Copies Should contain.
Clinical QA Data Audits A GCP Point of View Linda Del Paggio GCP Compliance BioBridges, LLC.
Good Clinical Practice in Research
1st Global QA Conference & 21st SQA Annual Meeting Falcon Consulting Group, LLC 1 Phase I Clinical Study Audits “A Deeper Scrutiny” Cheryl J. Priest, R.N.
Regulatory Submission Process  Clinical Study Application: 1. Submit an appointment requestappointment request 2. Fill one of the three templates: - BE.
Monitoring and Auditing
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
Paul Below, CCRA GCP Trainer Medical Research Management, Inc.
Developed by Klinikos; Roy Fraser (2012) Investigator Study File
John Naim, PhD Director Clinical Trials Research Unit
Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.
Good Clinical Practice GCP
Jennifer McCormick MA, CRC Karla Lichter RN CCRC.
Overview of Good Clinical Practices (GCPs)
Accredited Member of the Association of Clinical Research Professionals, USA Tips on clinical trials Maha Al-Farhan B.Sc, M.Phil., M.B.A., D.I.C.
Monitoring and Special Considerations for Multi-Center Trials
Regulatory Overview.
Assessment of Interchangeable Multisource Medicines Quality of BE Data Dr. Henrike Potthast Training workshop: Assessment of Interchangeable.
Good Clinical Practice (GCP)- An introduction Dr Noor Ibrahim Mohamed Sakian.
Regulatory Authority Governing Clinical Trials Anthony J. Minisi, MD Director, Cardiology Fellowship Program.
A S Nanivadekar Introduction to GCP. A S Nanivadekar Outline Definition and scope Definition and scope Purpose of clinical research Purpose of clinical.
Retha Britz Copyright 2013 All rights reserved for this presentation 1 Establishment and functioning of a REC Retha Britz.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
RESPONSIBILITIES OF INVESTIGATOR
STUDY CLOSE OUT KEMRI-Wellcome Trust Research Programme Version: 4-Nov-2008.
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
The Global Health Network Marijke Geldenhuys 19 September 2014 Adhering to the GCP Principles.. what does that even mean?
Legal & Ethical Issues. Objectives At the completion of this session the participant will be able to: ◦ Describe the ethical principles associated with.
Quality of Bioequivalence Data Alfredo García - Arieta Training workshop: Training of BE assessors, Kiev, October 2009.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
Boehringer Ingelheim Investigator Meeting Study POLO- AML-2 February 23, 2013/Toronto Behbood Sadrolhefazi Therapeutic Area Specialist/ Oncology.
AT I MPs GOOD CLINICAL PRACTICE Lola Briones, PhD, MBA BIO ROI Consulting SL M
Quality Assurance & Quality Control in Pharmaceuticals & Healthcare Industries By- Dr. Sushrut Varun Satpathy MBBS, MD Assistant Professor Department of.
Sponsor Visits and Monitoring
Good Clinical Practice (GCP) UKTMN 6 th June 2006.
Lifespan GOOD CLINICAL PRACTICE Record Management GCP May 2005.
ICH guidelines……….. INVESTIGATOR INVESTIGATOR Investigator's Qualifications and agreements The investigator(s) should be qualified by education, training,
Korea Food & Drug Administration Deputy director Kwang-Soo Joo Korea FDA Sep. 29, 2000 : Korean Good Clinical Practice & Relative Guidelines How to Manage.
Research Documentation Betty Wilson, CIP, MS Senior Compliance Manager MU IRB Lori Wilcox, EdD Director of Academic Compliance, Corporate Compliance.
Session 2 IRB Training  What is the Principal Investigator’s role in Human Subject Research?  What is the role of the Investigator’s staff in Human Subject.
Clinical Trial Terminologies. Abbreviated protocol A summary protocol containing brief information about the study which may be used as a concept document.
GCP (GOOD CLINICAL PRACTISE)
Responsibilities of Sponsor, Investigator and Monitor
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
Good Clinical Practice (GCP) and Monitoring Practices
Data Integrity – The Basis for “Generalizability” to Substantiate Change Balancing Efficacy with Clinical Power Frederick A. Curro, DMD, PhD PEARL Network.
Responsibilities of Sponsor, Investigator and Monitor
MAINTAINING THE INVESTIGATOR’S SITE FILE
Administering Informed Consent Issues for Discussion
Alyssa Speier, MS, CIP November 13, 2013
Good Clinical Practice
Regulatory Binder: Maintaining Essential Study Documentation
Basics of Building and Understanding Data Collection Forms
Gilbert Ogetii KEMRI-Wellcome Trust Research Programme Kilifi, Kenya
MAINTAINING THE INVESTIGATOR’S STUDY FILE
Good Clinical Practice in Research
Responsibilities of the Principal Investigator
Protocol Approval Criteria
Good clinical practice
S A Overarching SOPs Funding Secured Training Records
Presentation transcript:

Recapture of Day 1 Suchart Chongprasert, Ph.D. Food and Drug Administration “Practical Aspects in Performing Clinical and Bioanalytical Parts in BA/BE Studies” July 2006, Amari Airport Hotel

Source: D. O’Shaughnessy, GCP Audit/Inspection, Sept 3-4, 2001

Ethical and Regulatory Considerations importance of the review and approval / favorable opinion for the protocol proposed roles and responsibilities of the IEB/IEC safeguard rights, safety, and well-being conduct review and continuing review of a protocol ensuring compliance with the GCP, regulatory requirements etc. ethical principles: Declaration of Helsinki, Belmont Report IRB review process and criteria Placebo controlled trial? Informed Consent documents continuous dynamic process Document: comprehensible, lay language, not too long, translated version

Staff Training and Qualification Documentation Qualification: education, training, and experiences Put in updated CV periodically  Professional education  Research Experiences Training Requirements: Protocol/Investigator’s brochure/GCP/local regulations/reporting requirements Training source: Academic/Commercial/in-house Sponsor/international Conference

Investigational Drug Handling and Sample Retention Definition according to ICH: drug, human investigation Investigational product: manufactured, stored and used according to cGMP standard Define roles of sponsor relating to investigational product:  Safety and efficacy data: Investigator’s Brochure/Product Informational Leaflet  Details of investigational products: stability, acceptable conditions for storage etc. Define some experimental terms: Blinding/Randomization/Breaking Blind Retention of Samples: condition for storage, re use of the sample, how long, destruction after completion of the trial

Source Data And Source Documents Data all information of clinical findings, observation, or other activities in a clinical trial Source data are contained in the source documents  Original record  Certified copied of original records Source documents: hospital record, result of blood chemistry test, X-ray, microfilm, subject’s file laboratory notes etc. Electronic source data

Sample Source Document Source Data

Changes to data Data to be consistent with source and traceable to it at all times or difference to be explained in documentation. Subject records CRF Database Clarifications

Paper Audit Trail Example: Name of patient: Yung Ah Moi Yang Ah Moi initial date when changed reason for change (by person who made the change)

CRF Completion and Medical Review Source data/documents CRF Completion Clarification of CRF and Collection of CRF Data reported on the CRF, that are derived from source documents, should be consistent with the source documents or the discrepancies should be explained Data entry on CRF: clear, legible, understandable language, correction signed, dated, and reasoned Term and coding of term

Data Handling Process I (At the Site) CRF Collection Clarification of CRF Source Data Verification CRF Completion Source Data Note: Investigators have direct responsibilities for processes highlighted

Safety Reporting and Management Safety profile developed upon stage of non clinical and clinical development and actual clinical experiences after marketing Definition and classification of AE: severity, relationship, Expectations, Seriousness Serious ADR, AE Expedited report of AE: investigator’s, sponsor’s responsibility

Monitoring, Auditing, Inspecting Definition Monitoring: Sponsor’s responsibility, quality control for the conduct of trials Monitor: appointed by sponsor, overseeing the progress of the trial, and ensuring that it is conducted, recorded, reported according to SOP, GCP, applicable regulatory requirements CRF/Source Data Verification Audit: definition, types of audits Inspection: definition, reason for inspecting, level, classification of findings

Archiving Considerations: locations, accessibility, volume, charge, security, form of storage, hazards Why, by whom, what documents, how long, where, types Investigators and sponsors required to archive all trial related documents and ensure they are not lost or permanently destroy Essential documents: IB, protocol, signed informed consent, advertisement for recruitment, source documents, legal and financing agreements, insurance certificate, Cv, CRF, drug accountability records, IRB approval records